Who has invested in Elucida Oncology?

Lynx Financial are named among the investors backing Elucida Oncology.

Elucida Oncology Funding: $82M Raised, Series B (2021)

Elucida Oncology funding overview

Elucida Oncology is based in Monmouth Junction. Elucida Oncology has raised $82M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Elucida Oncology runs through 2021; nothing later has been disclosed. Investors on record include Lynx Financial.

Elucida Oncology at a glance

Total raised: $82M
Latest round: Series B
Latest round date: January 2021
Headquarters: Monmouth Junction
Notable investors: Lynx Financial

Frequently asked about Elucida Oncology funding

How much has Elucida Oncology raised?: Elucida Oncology has raised $82M in total disclosed funding across the rounds on record.
Who has invested in Elucida Oncology?: Lynx Financial are named among the investors backing Elucida Oncology.
What was the latest Elucida Oncology funding round?: The most recent disclosed round is a Series B, announced in January 2021.
Where is Elucida Oncology based?: Elucida Oncology is based in Monmouth Junction.
When did Elucida Oncology last raise?: The last disclosed Elucida Oncology round closed in January 2021 at Series B.

We update the Elucida Oncology record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Monmouth Junction and their backers are listed below.

Elucida Oncology Funding: $82M Raised, Series B (2021)

Elucida Oncology funding overview

Elucida Oncology at a glance

Frequently asked about Elucida Oncology funding

Companies related to Elucida Oncology (32)

Browse related funding lists (3)